image
DarioHealth Corp. DRIO
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 0.5776
3.14 %
$ 24 M
Market Cap
-0.95
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DRIO stock under the worst case scenario is HIDDEN Compared to the current market price of 0.578 USD, DarioHealth Corp. is HIDDEN

DRIO Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DRIO stock under the base case scenario is HIDDEN Compared to the current market price of 0.578 USD, DarioHealth Corp. is HIDDEN

DRIO Intrinsic Value
HIDDEN
SHOW

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one DRIO stock under the best case scenario is HIDDEN Compared to the current market price of 0.578 USD, DarioHealth Corp. is HIDDEN

DRIO Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart DRIO

image
1M -16%
6M -96%
1Y -127%
3Y -852%
5Y -1039%
All
$1.6$1.6$1.5$1.5$1.4$1.4$1.3$1.3$1.2$1.2$1.1$1.1$1.0$1.0$0.9$0.9$0.8$0.8$0.7$0.7$0.6$0.6$0.5$0.515 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
27 M REVENUE
32.86%
Growth Rates
1Year 32.86%
3Years 9.65%
5Years 29.04%
7Years 26.66%
10Years 87.26%
-57.7 M OPERATING INCOME
-2.77%
Growth Rates
1Year -2.77%
3Years 8.95%
5Years -26.67%
7Years -21.92%
10Years -17.66%
-42.7 M NET INCOME
28.07%
Growth Rates
1Year 28.07%
3Years 17.73%
5Years -19.24%
7Years -15.34%
10Years -12.75%
-38.6 M OPERATING CASH FLOW
-26.94%
Growth Rates
1Year -26.94%
3Years 8.54%
5Years -19.65%
7Years -20.23%
10Years -16.21%
-8.93 M INVESTING CASH FLOW
-1533.27%
Growth Rates
1Year -1533.27%
3Years -3.18%
5Years -139.66%
7Years -69.86%
10Years -35.47%
38.5 M FINANCING CASH FLOW
111.09%
Growth Rates
1Year 111.09%
3Years -16.32%
5Years 8.82%
7Years 16.21%
10Years 16.73%
7.6 M REVENUE
2.44%
Growth Rates
1Year 32.86%
3Years 9.65%
5Years 29.04%
7Years 26.66%
10Years 87.26%
-104 M OPERATING INCOME
-763.01%
Growth Rates
1Year -2.77%
3Years 8.95%
5Years -26.67%
7Years -21.92%
10Years -17.66%
-9.63 M NET INCOME
57.81%
Growth Rates
1Year 28.07%
3Years 17.73%
5Years -19.24%
7Years -15.34%
10Years -12.75%
-6.73 M OPERATING CASH FLOW
8.50%
Growth Rates
1Year -26.94%
3Years 8.54%
5Years -19.65%
7Years -20.23%
10Years -16.21%
-21 K INVESTING CASH FLOW
34.38%
Growth Rates
1Year -1533.27%
3Years -3.18%
5Years -139.66%
7Years -69.86%
10Years -35.47%
18.3 M FINANCING CASH FLOW
0.00%
Growth Rates
1Year 111.09%
3Years -16.32%
5Years 8.82%
7Years 16.21%
10Years 16.73%
Balance Sheet DarioHealth Corp.
image
Current Assets 28.6 M
Cash & Short-Term Investments 28.5 M
Receivables 0
Other Current Assets 175 K
Non-Current Assets 78.4 M
Long-Term Investments 0
PP&E 1.77 M
Other Non-Current Assets 76.6 M
26.60 %71.58 %Total Assets$107.0m
Current Liabilities 16.6 M
Accounts Payable 3.04 M
Short-Term Debt 5.96 M
Other Current Liabilities 7.64 M
Non-Current Liabilities 30.2 M
Long-Term Debt 24.2 M
Other Non-Current Liabilities 5.99 M
6.50 %12.71 %16.29 %51.72 %12.79 %Total Liabilities$46.9m
EFFICIENCY
Earnings Waterfall DarioHealth Corp.
image
Revenue 27 M
Cost Of Revenue 13.8 M
Gross Profit 13.3 M
Operating Expenses 71 M
Operating Income -57.7 M
Other Expenses -15 M
Net Income -42.7 M
30m30m20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)27m(14m)13m(71m)(58m)15m(43m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
49.06% GROSS MARGIN
49.06%
Averages
1Year 49.06%
3Years 37.79%
5Years 33.17%
7Years 32.01%
10Years 12.56%
-213.55% OPERATING MARGIN
-213.55%
Averages
1Year -213.55%
3Years -231.68%
5Years -292.53%
7Years -276.59%
10Years -354.64%
151.56% NET MARGIN
151.56%
Averages
1Year 151.56%
3Years -121.77%
5Years -224.43%
7Years -228.28%
10Years -315.87%
56.90% ROE
56.90%
Averages
1Year 56.90%
3Years -41.01%
5Years -63.15%
7Years -87.04%
10Years -176.15%
34.47% ROA
34.47%
Averages
1Year 34.47%
3Years -26.45%
5Years -47.48%
7Years -62.30%
10Years -108.42%
0.00% ROIC
0.00%
Averages
1Year 0.00%
3Years -38.70%
5Years -61.13%
7Years -84.47%
10Years -237.56%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DarioHealth Corp.
image
00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Net Income -42.7 M
Depreciation & Amortization 7.43 M
Capital Expenditures -138 K
Stock-Based Compensation 15.8 M
Change in Working Capital -2.47 M
Others -17.5 M
Free Cash Flow -38.7 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DarioHealth Corp.
image
Wall Street analysts predict an average 1-year price target for DRIO of $13.2 , with forecasts ranging from a low of $7.5 to a high of $18 .
DRIO Lowest Price Target Wall Street Target
7.5 USD 1198.48%
DRIO Average Price Target Wall Street Target
13.2 USD 2179.55%
DRIO Highest Price Target Wall Street Target
18 USD 3016.34%
Price
Max Price Target
Min Price Target
Average Price Target
181816161414121210108866442200May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 6
6. Ownership
Insider Ownership DarioHealth Corp.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
4.63 K USD 2
3-6 MONTHS
66.7 K USD 2
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
DarioHealth (DRIO) Upgraded to Strong Buy: Here's What You Should Know DarioHealth (DRIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 2 weeks ago
Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth NEW YORK--(BUSINESS WIRE)--Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to recent reports could reach $3-6 billion despite recent market volatility, DarioHealth's comprehensive AI. businesswire.com - 2 weeks ago
DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript DarioHealth Corp. (NASDAQ:DRIO ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Steven Nelson - Chief Commercial Officer Conference Call Participants Charles Rhyee - TD Cowen Ashok Kumar - ThinkEquity David Grossman - Stifel Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth Fourth Quarter 2024 Results Conference Call. At this time, all lines are in listen-only mode. seekingalpha.com - 1 month ago
Market News Alert: DarioHealth Beats Q4 Expectations, Reports 398% Growth in B2B Recurring Revenue NEW YORK--(BUSINESS WIRE)---- $DRIO #Biotech--Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. Gross margins in the B2B2C business exceeded 80% over the past three quarters. Full-year 2024 revenue reached $2. businesswire.com - 1 month ago
DarioHealth Reports Fourth Quarter and Full year 2024 Financial and Operating Results Full-year 2024 revenue increased by 32.9% to $27.0 million from $20.4 million revenue in 2023. Revenue growth driven by B2B2C channel including employers and health plans resulting in recurring revenues which increased by 300% year over year as core business continues to gain traction. prnewswire.com - 1 month ago
Dario Expands Behavioral Health Offerings to Include a Provider Network Through Strategic Arrangement with Rula The strategic arrangement fuels Dario's B2B2C sales growth, expanding access to over 15,000 providers nationwide NEW YORK , March 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a strategic collaboration with Rula Health, a leading provider of high-quality behavioral health services, to expand access to mental health support for employers and their workforce nationwide. Through this strategic collaboration, Dario clients will have access to Rula's extensive network of over 15,000 providers across the country with coverage of over 120 million commercial lives through most major insurance networks. prnewswire.com - 1 month ago
Dario Signs First Healthcare System as Employer Contract, Expanding Market Presence and Recurring Revenue Growth Healthcare system collaborates with Dario to offer AI-powered chronic care management solutions as a benefit for their employee base of healthcare workers, expected to contribute to the current total of 15 new client signings in 2025, representing a significant head start in its 2025 net new client goal. NEW YORK , March 5, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today the signing of a contract with a major healthcare system to be added to its employer book of business, set to go live in the first quarter of 2025. prnewswire.com - 1 month ago
DarioHealth to Report Fourth Quarter and Full Year 2024 Results on Monday, March 10, 2025 Company to host conference call and webcast at 8:30am Eastern Time NEW YORK , March 4, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 4th quarter ended December 31 st, 2024 and will host a conference call and webcast at 8:30 am Eastern Time, on Monday, March 10 th, 2025, before the market opens. Erez Raphael, Chief Executive Officer, and Steven Nelson, Chief Commercial Officer, will host the call. prnewswire.com - 1 month ago
DarioHealth Appoints Healthcare Industry Leader Larry Leisure to Board of Directors Healthcare innovator and former Accenture executive brings deep industry relationships to advance Dario's AI-driven chronic care platform. NEW YORK , Feb. 27, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in AI-driven digital health solutions, today announced the appointment of Lawrence (Larry) B. prnewswire.com - 1 month ago
Market News Alert: DarioHealth Secures Significant New Agreement, Expanding Growth in the $1.2 Trillion Dollar Cardiometabolic Market NEW YORK--(BUSINESS WIRE)---- $DRIO #AI--Market News Alerts Updates: DarioHealth Corp. (Nasdaq: DRIO)* has announced a significant new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a pivotal expansion in the fast-growing digital health landscape. This move integrates Dario's AI-driven cardiometabolic digital health solutions, covering diabetes, hypertension, and weight management, into the offerings of one of America's most trusted health insurers. According to a recent report, the card. businesswire.com - 2 months ago
DarioHealth Announces New Blue Cross Blue Shield Agreement, Expanding Health Plan Client Base DarioHealth expands its payer network with a new Blue Cross Blue Shield agreement, bolstering recurring revenue growth and reinforcing its position in one of healthcare's fastest-growing sectors; Dario's AI-driven digital health platform continues to drive adoption among payers seeking scalable, data-driven solutions NEW YORK , Feb. 6, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced that it has secured a new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a significant expansion of its presence in the health plan market. The program, rolled out in January 2025, allows members seamless access to Dario's evidence-based, AI-driven health coaching and monitoring tools. prnewswire.com - 2 months ago
PESG Report: DarioHealth Positions Itself as a Market Leader in the Multi-Billion-Dollar Digital Health Transformation NEW YORK--(BUSINESS WIRE)---- $DRIO #GLP1--PESG Releases Report: In a healthcare market brimming with potential, DarioHealth Corp. (Nasdaq: DRIO)* is quietly emerging as a standout player, combining cutting-edge technology with proven outcomes. Looking at recent achievements, it seems DarioHealth's multi-condition digital health platform and its accelerating financial trajectory may position it as a sleeper hit in a rapidly growing sector. Breaking Down the Opportunity At the heart of DarioHealth's success is. businesswire.com - 2 months ago
8. Profile Summary

DarioHealth Corp. DRIO

image
COUNTRY US
INDUSTRY Medical - Diagnostics & Research
MARKET CAP $ 24 M
Dividend Yield 0.00%
Description DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Contact 18 West 18th Street, New York, NY, 10011 https://www.mydario.com
IPO Date March 14, 2016
Employees 196
Officers Mr. Steven C. Nelson Chief Commercial Officer Mr. Zvi Ben David CPA Chief Financial Officer, Treasurer & Secretary Ms. Mona Dean Chief Compliance Officer Claudia Levi Content & Communications Manager Lara Dodo Chief Operations Officer Dov Oppenheim Co-Founder & Production Chief Limor Drezner Chief People Officer Mr. Tomer Ben-Kiki Chief Technology Officer Mr. Erez Raphael Chief Executive Officer & Director Kat Parrella Investor Relations Manager